News

Bus Shelter Campaign in Barcelona Brings Scientific Health Evidence Closer to the Public

The outreach projects of the Iberoamerican Cochrane Centre (CCIb) will be visible on the streets of Barcelona during this Holy Week through a communication campaign aimed at bringing scientific health...

Brain Hypometabolism: An Early Sign of Alzheimer’s in People with Down Syndrome

A team from the Sant Pau Research Institute (IR Sant Pau), in collaboration with the Catalan Down Syndrome Foundation, has published in the journal Annals of Neurology the largest study to date on bra...

Identifying the Factors That Accelerate Full FDA Approval of Oncology Drugs

A study led by Dr. Ariadna Tibau, researcher at the Sant Pau Research Institute (IR Sant Pau) and oncologist at Hospital de Sant Pau, was recently published in the journal JAMA Network Open. The artic...

A Targeted Nanotoxin Activates the Immune Response and Slows Colorectal Cancer Growth in Preclinical Models

Researchers from the Sant Pau Research Institute (IR Sant Pau) have demonstrated, in a preclinical study, the effectiveness of a targeted nanotoxin in inhibiting colorectal cancer growth. The study, p...

Dapagliflozin Improves Heart Failure Treatment in Older Patients with Aortic Stenosis

The Sant Pau Research Institute (IR Sant Pau), together with the Hospital de Sant Pau, has participated in the DapaTAVI clinical trial, which has shown that the use of the drug dapagliflozin significa...